SDAI gets shareholder nod to enter biotech and anti-ageing business

It targets the longevity market with skincare, supplements and moxibustion push.

SDAI Limited has obtained shareholder approval to diversify into the biotechnology business at an extraordinary general meeting held on 30 April.

In a statement, the company said the diversification will cover biotechnology activities related to the development, distribution, and provision of anti-ageing and longevity-focused healthcare products and services.

SDAI cited growth in the global anti-ageing market, estimated at $101.51b (USD80b) in 2025 and projected to reach $173.96b (USD137.1b) by 2035.

It also referenced the Research, Innovation and Enterprise 2030 (RIE2030) plan, which will invest $37b in research and innovation from April 2026, including healthy longevity initiatives.

The group said it has already begun activities in the sector, including a strategic cooperation agreement with LiveBeyond Pte. Ltd. in August 2025 for anti-ageing research and applications.

In December 2025, SDAI launched its Bluecode Biotech B-III skincare series in China and Singapore, with products distributed through e-commerce platforms including Lazada and Shopee.

In January 2026, it entered into a joint venture with Hubei Qiai Group Co., Ltd., QCM Holdings Pte. Ltd., and QCM International Pte. Ltd. to expand moxibustion-related products in ASEAN including setting up a moxibustion experience centre in Singapore.

SDAI said the diversification will allow it to pursue biotechnology-related transactions more efficiently without requiring separate shareholder approvals for each deal.

$1.27 = USD1

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia